1 study on ANGIO-3 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Peptide Angio-3 represents a novel and highly promising therapeutic strategy for pulmonary fibrosis, offering a unique mechanism of action by targeting the coagulation Factor Xa-PAR-1 signaling axis. This study provid…